Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Nov 30, 2023

SELL
$15.45 - $26.02 $3,553 - $5,984
-230 Closed
0 $0
Q2 2022

Nov 30, 2023

BUY
$13.27 - $25.5 $3,052 - $5,865
230 New
230 $4.15 Million

Others Institutions Holding IGMS

About IGM Biosciences, Inc.


  • Ticker IGMS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,969,000
  • Market Cap $517M
  • Description
  • IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...
More about IGMS
Track This Portfolio

Track Pfs Partners, LLC Portfolio

Follow Pfs Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfs Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pfs Partners, LLC with notifications on news.